Publication & Citation Trends
Publications
0 total
Pembrolizumab with or without chemotherapy versus chemotherapy alone for patients with PD-L1–positive advanced gastric or gastroesophageal junction adenocarcinoma: Update from the phase 3 KEYNOTE-062 trial.
Cited by 20
Semantic Scholar
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab{plus minus}Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study. OA
Cited by 62
Semantic Scholar
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study OA
Cited by 192
Semantic Scholar
Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer OA
Cited by 15
Semantic Scholar
FP13.04 KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ Locally Advanced/Metastatic NSCLC OA
Cited by 26
Semantic Scholar
363 KEYNOTE-042 5-year survival update: pembrolizumab versus chemotherapy in patients with previously untreated, PD-L1–positive, locally advanced or metastatic non–small-cell lung cancer OA
Cited by 10
Semantic Scholar
MO01.41 Using an Exploratory Composite Endpoint to Evaluate the Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer OA
Cited by 0
Semantic Scholar
1442P Association of TMB using the Foundation Medicine Companion Diagnostic (F1CDx) with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (pembro + chemo) versus chemo in patients with gastric cancer (gc) from KEYNOTE-062 OA
Cited by 14
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(24)
Gastric Cancer Management and Outcomes
(17)
Lung Cancer Treatments and Mutations
(11)
Gastrointestinal Tumor Research and Treatment
(9)
Cancer Genomics and Diagnostics
(5)
Affiliations
Latvian Biomedical Research and Study Centre
Peter MacCallum Cancer Centre
Riga East University Hospital
Riga Aeronautical Institute
University of Latvia